期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Ⅰb～Ⅱa期子宫颈鳞癌淋巴结转移相关因子的检测及风险预测模型的建立和验证 被引量：2

原文传递
导出
摘要 宫颈癌为全球妇女第二大恶性肿瘤，淋巴结转移是其显著的预后影响因素^[1]。早期宫颈癌的浸润转移是一个多步骤、多因素过程，包括癌细胞与细胞外基质的黏附、酶解和运动等，涉及到多种转移相关因子，如细胞黏附分子变异体6（CD44v6）、上皮型钙黏附素（E—cad）、基质金属蛋白酶（MMP）2、MMP-9、MMP-7、
作者 吴素慧 李颖 张静 尚海霞
机构地区 山西医科大学第一医院妇科
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第5期376-378,共3页 Chinese Journal of Obstetrics and Gynecology
基金 山西省自然科学基金（2006011121） 山西省科技攻关项目（2007031091-6）
关键词 转移相关因子 淋巴结转移 子宫颈鳞癌 预测模型 Ⅱa期 细胞黏附分子 上皮型钙黏附素 基质金属蛋白酶
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1吴素慧,张静,李颖,尚海霞,马纪华.子宫颈癌Ⅰb和Ⅱa期患者预后相关因素的分析[J].中华妇产科杂志,2007,42(2):131-132. 被引量：8
  • 2张声,李莉,林华,林建银.胃癌淋巴结转移相关因素的多元分析[J].中华肿瘤杂志,2001,23(5):399-402. 被引量：45
  • 3Pickel H,Haas J,Lahousen M.Prognostic factors in cervical cancer.Eur J Obstet Cynecol Reprod Biol,1997,71:209-213.
  • 4Branca M,Ciotti M,Ciorgi C,et al.Matrix metalloproteinaae-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer,related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.Anticancer Res,2006,26:1543-1556.
  • 5Restucci B,Martano M,DE Vico G,et al.Expression of E-cadherin,beta-catenin and APC protein in canine colorectal tumours.Anticancer Res,2009,29:2919-2925.
  • 6Ii M,Yamamoto H,Adachi Y,et al.Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion,apoptosis,growth,and angiogenesis.Exp Biol Med (Maywood),2006,231:20-27.
  • 7Wu ZS,Wu Q,Yang JH,et al.Prognostic significance of MMP-9 and T1MP-1 serum and tissue expression in breast cancer.Int J Cancer,2008,122:2050-2056.
  • 8Jin H,Varner J.Integrins; roles in cancer development and as treatment targets.Br J Cancer,2004,90:561-565.
  • 9Boye K,Maelandsmo CM.S100A4 and metastasis; a small actor playing many roles.Am J Pathol,2010,176:528-535.
  • 10Chhatwal J,Alagoz 0,Lindstrom MJ,et al.A logistic regression model based on the national mammography database format to aid breast cancer diagnosis.AJR Am J Roentgenol,2009,192:1117-1127.

二级参考文献12

  • 1李莉 张声 等.CD44v6表达与胃癌浸润转移呈正相关[J].临床实验与病理学杂志,2000,16:39-41.
  • 2李莉，临床与实验病理学杂志，2000年，16卷，增刊，39页
  • 3中国抗癌协会，新编常见恶性肿瘤诊治规范.胃癌分册，1999年，1页
  • 4Zreik TG,Chambers JT,Chambers SK.Parametrial involvement,regardless of nodal status:a poor prognostic factor for cervical cancer.Obstet Gynecol,1996,87:741-746.
  • 5Memarzadeh S,Natarajan S,Dandade DP,et al.Lymphovascular and perineural invasion in the parametria:a prognostic factor for early-stage cervical cancer.Obstet Gynecol,2003,102:612-619.
  • 6Panek G,Kaminska G,Zielinski J.The influence of selected prognostic factors on the results of combined treatment of invasive carcinoma of the cervix on stage IB and stage IIA.Ginekol Pol,1999,70:484-489.
  • 7Tay SK,Tan LK.Outcome of early cervical carcinoma treated by Wertheim hysterectomy with selective postoperative radiotherapy.Ann Acad Med Singapore,1998,27:613-617.
  • 8Kobierski J,Emerich J,Krolikowska B,et al.Lymph node metastasis as a prognostic factor in cervical carcinoma.Ginekol Pol,2002,73:925-929.
  • 9Aoki Y,Sasaki M,Watanabe M,et al.High-risk group in nodepositive patients with stage IB,IIA,and IIb cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.Gynecol Oncol,2000,77:305-309.
  • 10Peters WA 3rd,Liu PY,Barrett RJ 2nd,et al.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.J Clin Oncol,2000,18:1606-1613.

共引文献51

同被引文献25

  • 1李颖,张静,李建民,吴素慧.利用组织芯片检测上皮型钙黏素在宫颈癌浸润转移中的作用[J].山西医科大学学报,2006,37(5):468-469. 被引量：1
  • 2刘嵘,濮德敏,程艳香,尹伶.受体结合肿瘤抗原、血管内皮生长因子和基质金属蛋白酶-9在宫颈癌组织中的表达及其与肿瘤侵袭、转移的关系[J].中华医学杂志,2007,87(19):1326-1329. 被引量：5
  • 3Tarnowski M,Grymula K,Liu R,et al.Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells,modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts[J].Mol Cancer Res,2010,8(10):1328-1343.
  • 4McClelland M,Zhao L,Carskadon S,et al.Expression of CD74,the receptor for macrophage migration inhibitory factor,in nonsmall cell lung cancer[J].Am J Pathol,2009,174(2):638-646.
  • 5Tawadros T,Alonso F,Jichlinski P,et al.Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells[J].Endocr Relat Cancer,2013,20(1):137-149.
  • 6Verjans E,Noetzel E,Bektas N,et al.Dual role of macrophage migration inhibitory factor(MIF)in human breast cancer[J].BMC Cancer,2009,14(9):230.
  • 7Gales D,Clark C,Manne U,et al.The chemokine CXCL8 in carcinogenesis and drug response[J].ISRN Oncol,2013,2013:859154.
  • 8Ning Y,Manegold PC,Hong YK,et al.Interleukin-8 is associated with proliferation,migration,angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models[J].Int J Cancer,2011,128(9):2038-2049.
  • 9Matheus ER,Zonta MA,Discacciati MG.MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears[J].Diagn Cytopathol,2014,42(10):827-833.
  • 10Bach JP,Rinn B,Meyer B,et al.Bacher M.Role of MIF in inflammation and tumorigenesis[J].Oncology,2008,75(3/4):127-133.

引证文献2

二级引证文献9

中华妇产科杂志
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部